DBVT - DBV Technologies S.A.
21.87
-0.210 -0.960%
Share volume: 357,965
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$22.08
-0.21
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 07-30-2024 | 11-06-2024 | 04-30-2025 | 07-29-2025 | 10-28-2025 | |
| Assets | |||||||
| Total Assets | 145.895 M | 114.190 M | 93.055 M | 50.562 M | 143.429 M | 110.495 M | |
| Current Assets | 119.562 M | 89.958 M | 68.759 M | 29.148 M | 121.241 M | 88.882 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 18.037 M | 23.745 M | 22.318 M | 16.186 M | 18.034 M | 19.045 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 101.525 M | 66.213 M | 46.441 M | 12.962 M | 103.207 M | 69.837 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 12.913 M | 12.874 M | 12.984 M | 10.813 M | 11.055 M | 10.536 M | |
| Other Assets | 13.421 M | 11.358 M | 11.311 M | 10.602 M | 11.134 M | 11.077 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 145.895 M | 114.190 M | 93.055 M | 50.562 M | 143.429 M | 110.495 M | |
| Total liabilities | 34.241 M | 35.095 M | 39.021 M | 47.688 M | 57.205 M | 57.641 M | |
| Total current liabilities | 26.483 M | 27.381 M | 30.913 M | 40.384 M | 49.425 M | 49.485 M | |
| Accounts Payable | 18.076 M | 19.818 M | 22.500 M | 34.146 M | 40.792 M | 39.816 M | |
| Other liabilities | 7.758 M | 7.714 M | 8.108 M | 7.305 M | 7.780 M | 8.156 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 7.758 M | 7.714 M | 8.108 M | 7.305 M | 7.780 M | 8.156 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 111.652 M | 79.095 M | 54.034 M | 2.873 M | 86.224 M | 52.853 M | |
| Common stock | 390.398 M | 325.491 M | 327.081 M | 328.965 M | 406.939 M | 407.456 M | |
| Retained earnings | -266.207 M | -232.890 M | -263.332 M | -313.454 M | -315.136 M | -348.301 M |